3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 3
3
Phase 2/3
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
51
pembrolizumab
46
Magnetic Resonance Spectroscopy
38
Biopsy
37
Cyclophosphamide
34
fludarabine
29
Cetuximab
20
Cisplatin
19
Carboplatin
19
Radiotherapy
16
Bevacizumab
16
atezolizumab
15
Radiation
15
venetoclax
14
Nivolumab
14
Fluorouracil
14
fludarabine phosphate
13
Leucovorin
13
Gemcitabine
13
Temozolomide
11
Pemetrexed
11
Oxaliplatin
11
Cytarabine
11
Paclitaxel
10
Irinotecan
10
Ipilimumab
10
130-nm albumin-bound paclitaxel
10
Prednisone
9
Immunoglobulin G
9
Fulvestrant
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
relatlimab
×
30 days
×
Clear all
NCT05176483
2026-05-27
STELLAR-002
Exelixis
Phase 1
Recruiting
1,314 enrolled